Page last updated: 2024-10-30

maprotiline and Benign Neoplasms

maprotiline has been researched along with Benign Neoplasms in 2 studies

Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.

Research Excerpts

ExcerptRelevanceReference
"20 patients with neuropathic pain syndromes due to tumor-infiltration, who had not responded to conventional analgesics including strong opioids, received additional combination anti-convulsant and anti-depressant treatment."1.28Anti-depressants and anti-convulsants for the treatment of neuropathic pain syndromes in cancer patients. ( Höffken, K; Kloke, M; Olbrich, H; Schmidt, CG, 1991)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byun, S1
Lee, E1
Lee, KW1
Kloke, M1
Höffken, K1
Olbrich, H1
Schmidt, CG1

Reviews

1 review available for maprotiline and Benign Neoplasms

ArticleYear
Therapeutic Implications of Autophagy Inducers in Immunological Disorders, Infection, and Cancer.
    International journal of molecular sciences, 2017, Sep-12, Volume: 18, Issue:9

    Topics: Adaptive Immunity; Animals; Autoimmune Diseases; Autophagy; Benzylisoquinolines; Cholecalciferol; Hu

2017

Other Studies

1 other study available for maprotiline and Benign Neoplasms

ArticleYear
Anti-depressants and anti-convulsants for the treatment of neuropathic pain syndromes in cancer patients.
    Onkologie, 1991, Volume: 14, Issue:1

    Topics: Analgesics; Anticonvulsants; Antidepressive Agents; Clomipramine; Drug Therapy, Combination; Haloper

1991